These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6526540)

  • 21. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response.
    Tvedskov JF; Thomsen LL; Thomsen LL; Iversen HK; Williams P; Gibson A; Jenkins K; Peck R; Olesen J
    Cephalalgia; 2004 Dec; 24(12):1076-87. PubMed ID: 15566422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
    Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
    Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
    Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis.
    Alvarez D; de las Heras M; Abecasis R; Terg R; Gerona S; Albornoz L; Galdame O; Torres J; Mastai R
    Hepatology; 1997 Mar; 25(3):548-50. PubMed ID: 9049196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elimination of paracetamol in chronic liver disease.
    Arnman R; Olsson R
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):283-6. PubMed ID: 696204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary gastrin output and serum gastrin in patients with liver cirrhosis. Urinary gastrin output in cirrhosis.
    Avgerinos A; Dimitriou-Voudri Y; Adamopoulos A; Papadimitriou N; Voudris B; Rekoumis G; Raptis S
    Hepatogastroenterology; 1994 Oct; 41(5):445-8. PubMed ID: 7851853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism for reduced drug clearance in patients with cirrhosis.
    Pessayre D; Lebrec D; Descatoire V; Peignoux M; Benhamou JP
    Gastroenterology; 1978 Mar; 74(3):566-71. PubMed ID: 631487
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.
    Genesca J; Segura R; Gonzalez A; Catalan R; Marti R; Torregrosa M; Cereto F; Martinez M; Esteban R; Guardia J
    Am J Gastroenterol; 2000 Jun; 95(6):1539-44. PubMed ID: 10894593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circadian variations of histamine binding to lymphocytes and neutrophils and skin reactivity to histamine in atopic and healthy subjects.
    Zak-Nejmark T; Nowak IA; Kraus-Filarska M
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):283-7. PubMed ID: 16868722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver function and encephalopathy after partial vs direct side-to-side portacaval shunt: a prospective randomized clinical trial.
    Capussotti L; Vergara V; Polastri R; Bouzari H; Galatola G
    Surgery; 2000 Jun; 127(6):614-21. PubMed ID: 10840355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
    Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
    Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
    Clements JD; Jamali F
    Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of influence of aluminum hydroxide on the bioavailability and beta-adrenoceptor blocking activity of propranolol.
    Hong CY; Hu SC; Lin SJ; Chiang BN
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):244-6. PubMed ID: 4008113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of a predictive model of ambulatory blood pressure integrating physical activity].
    Siché JP; Marques F; Charbonnier S; Baguet JP; Diourte B; Mallion JM
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1103-9. PubMed ID: 9404417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Portocaval shunt throughout anhepatic phase in orthotopic liver transplantation for cirrhotic patients.
    de Cenarruzabeitia IL; Lázaro JL; Bilbao I; Balsells J
    Transplant Proc; 2007 Sep; 39(7):2280-4. PubMed ID: 17889163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of beta-blocker on intractable ascites in cirrhotic patients undergoing hepatectomy for hepatocellular carcinoma.
    Kondo M; Nagano H; Sakon M; Hayashi S; Okami J; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Hepatogastroenterology; 2003; 50(50):504-6. PubMed ID: 12749257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.